25.04.2024 15:45 | APTA | Holding(s) in Company | RNS |
24.04.2024 08:45 | APTA | Holding(s) in Company | RNS |
23.04.2024 14:03 | APTA | Holding(s) in Company - REPLACEMENT | RNS |
22.04.2024 20:03 | TPOU, MHN, CCL | EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings | Alliance |
22.04.2024 16:37 | APTA | Holding(s) in Company | RNS |
22.04.2024 07:00 | APTA | Top Pharma Company evaluates Optimer for medicine | RNS |
18.04.2024 11:54 | APTA | Aptamer inks new Optimer+ transplant rejection therapy partnership | Alliance |
18.04.2024 10:06 | APTA | TR-1: Notification of major holdings | RNS |
18.04.2024 07:00 | APTA | Aptamer and Kairos Biotech partner for Optimer+ | RNS |
08.04.2024 14:27 | ULVR, APTA | Aptamer submits patent application for Optimer binders | Alliance |
08.04.2024 07:00 | APTA | Patent submission for Optimer® binders | RNS |
28.03.2024 14:07 | APTA | Holding(s) in Company | RNS |
28.03.2024 12:29 | ARBB, APTA, GSC | EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles | Alliance |
28.03.2024 07:00 | APTA | Interim Results | RNS |
22.03.2024 07:00 | APTA | Notice of Interim Results & Investor Presentation | RNS |
14.03.2024 07:00 | APTA | Investor Webinar | Reach |
11.03.2024 11:08 | APTA, ULVR | Aptamer shares jump on successful Unilever contract progression | Alliance |
11.03.2024 07:00 | APTA | Aptamer Progresses Partnership with Unilever | RNS |
29.02.2024 07:00 | APTA | Block Listing Interim Review | RNS |
27.02.2024 14:27 | APTA | Aptamer says new Optimer+ delivers improved results | Alliance |
27.02.2024 07:00 | APTA | R&D progress on new Optimer®+ platform | RNS |
22.02.2024 13:21 | APTA | Aptamer and Neuro-Bio begin Alzheimer's test development second phase | Alliance |
22.02.2024 07:00 | APTA | Second Phase of Alzheimer's test with Neuro-Bio | RNS |
05.02.2024 11:25 | APTA | Aptamer shares plunge as half-year revenue to fall by 70% | Alliance |
05.02.2024 07:00 | APTA | Half Year Trading Update | RNS |
04.01.2024 14:39 | APTA | Holding(s) in Company | RNS |
15.12.2023 15:57 | APTA | Results of 2023 Annual General Meeting | RNS |
15.12.2023 07:00 | APTA | AGM Statement | RNS |
14.12.2023 14:25 | APTA | IN BRIEF: Aptamer inks deal for Optimer discovery with biotech firm | Alliance |
14.12.2023 07:00 | APTA | Material Agreement with Genetic Medicines Company | RNS |
08.12.2023 14:54 | ULTP, SREI, RENX | UK shareholder meetings calendar - next 7 days | Alliance |
20.11.2023 07:00 | APTA | Posting of Annual Report and Notice of AGM | RNS |
09.11.2023 18:11 | RGL, SOUC, APTA | EARNINGS AND TRADING: Aptamer revenue falls, loss widens | Alliance |
09.11.2023 07:00 | APTA | Full year results for the 12mths ended 30 Jun 2023 | RNS |
08.11.2023 12:20 | APTA | Notice of Results and Investor Presentation | RNS |
06.11.2023 10:59 | APTA | Aptamer says interim revenue to fall due to weak customer confidence | Alliance |
06.11.2023 10:24 | APTA, POS, STG | AIM WINNERS & LOSERS: Strip Tinning and Plexus win deals | Alliance |
06.11.2023 07:00 | APTA | Trading Update | RNS |
24.10.2023 10:16 | APTA | Holding(s) in Company | RNS |
09.10.2023 09:40 | APTA | Grant of Options and Related Party Transaction | RNS |
19.09.2023 21:57 | APTA | IN BRIEF: Aptamer raises GBP310,772 through subscription and placing | Alliance |
19.09.2023 14:35 | APTA | Placing and Subscription, PDMR Dealing and TVR | RNS |
13.09.2023 12:58 | APTA | Holding(s) in Company | RNS |
31.08.2023 07:00 | APTA | Holding(s) in Company | RNS |
24.08.2023 18:09 | APTA | Holding(s) in Company | RNS |
24.08.2023 18:05 | APTA | Holding(s) in Company | RNS |
21.08.2023 13:20 | APTA | Holding(s) in Company | RNS |
21.08.2023 13:17 | APTA | Holding(s) in Company | RNS |
17.08.2023 16:48 | APTA | UPDATE: Aptamer launches cost-cutting blitz as it targets break-even | Alliance |
17.08.2023 12:47 | APTA | Result of General Meeting | RNS |
17.08.2023 09:30 | APTA | Aptamer hails contracts with "top five pharma partner" | Alliance |
17.08.2023 07:00 | APTA | Contract wins | RNS |
15.08.2023 17:43 | APTA | TR-1 | RNS |
15.08.2023 17:40 | APTA | TR-1 | RNS |
31.07.2023 10:46 | SCLP, TYM, APTA | AIM WINNERS & LOSERS: Aptamer reshuffles board; Scancell expands trial | Alliance |
31.07.2023 10:18 | APTA | Aptamer terminates sales process after fundraise; CEO and CFO resign | Alliance |
31.07.2023 09:04 | APTA | Form 8.5 (EPT/RI) | RNS |
31.07.2023 07:01 | APTA | Update on Strategic Review and Formal Sale Process | RNS |
31.07.2023 07:00 | APTA | Fundraise, Proposed Board Changes, RPT, GM Notice | RNS |
28.07.2023 08:57 | APTA | Form 8.5 (EPT/RI) | RNS |
27.07.2023 09:36 | APTA | Form 8.5 (EPT/RI) - Aptamer Group PLC | RNS |
26.07.2023 21:46 | TRAF, APTA, TRAC | TRADING UPDATES: Van Elle profit rises; Costain financing pact | Alliance |
26.07.2023 10:57 | APTA | Response to Speculation, Strategic Review, Update | RNS |
07.07.2023 10:37 | HE1, QED, APTA | AIM WINNERS & LOSERS: Aptamer shares claw back some lost ground | Alliance |
07.07.2023 09:28 | APTA | Aptamer shares surge on signing of four new contracts worth GBP507,000 | Alliance |
07.07.2023 07:00 | APTA | Contract Wins | RNS |
04.07.2023 10:32 | APTA, RST, ALBA | AIM WINNERS & LOSERS: Alba wins permits; Aptamer cash-strapped | Alliance |
04.07.2023 09:31 | APTA | Aptamer shares plummet as revenue falls, recquires further funding | Alliance |
04.07.2023 07:00 | APTA | Trading Update | RNS |
14.06.2023 13:41 | APTA | IN BRIEF: Aptamer notes share jump, not aware of reason for rise | Alliance |
14.06.2023 12:16 | APTA | Response to Share Price Movement | RNS |
14.06.2023 09:50 | SLE, GCM, APTA | AIM WINNERS & LOSERS: Aptamer soars on Alzheimer's test success | Alliance |
14.06.2023 09:25 | APTA | Aptamer shares soar after success in rapid Alzheimer test development | Alliance |
14.06.2023 07:00 | APTA | Aptamer & Neuro-Bio to develop Alzheimer’s test | Reach |
10.05.2023 12:08 | APTA | IN BRIEF: Aptamer CEO Arron Tolley resigns with immediate effect | Alliance |